As of December 15, 2025, Vir Biotechnology Inc (VIR) reports a Graham Number of 36.51.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Vir Biotechnology Inc's Graham Number
Over recent years, Vir Biotechnology Inc's Graham Number has shown a stable trend. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2024-12-31 | 36.51 |
| 2023-12-31 | 35.30 |
| 2022-12-31 | 29.66 |
This steady improvement highlights how Vir Biotechnology Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Vir Biotechnology Inc's Graham Number to Peers
To better understand Vir Biotechnology Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Vir Biotechnology Inc (VIR) | 36.51 |
| Regeneron Pharmaceuticals Inc (REGN) | 513.65 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Agios Pharmaceuticals Inc (AGIO) | 82.89 |
| Madrigal Pharmaceuticals Inc (MDGL) | 60.40 |
Compared to its competitors, Vir Biotechnology Inc's Graham Number is about average compared to peers, reflecting standard fundamental metrics for the industry.